Stock listing

Hanover:F3M Tempus AI, Inc. Aktie

German listing (Hanover) of Tempus AI, Inc. · home listing NASDAQ:TEM

Follow Tempus AI, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:TEM

$54.04 USD -9.58 (-15.1%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:TEM

Past year -17.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$53.26 – $58.35 USDNov 20, 2026
Volume
7.42M sharesNov 20, 2026
Market cap
$9.58B USDAt the close on Nov 20, 2026 · price × 177.4M shares outstanding
52-week range
$40.77 – $89.09 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$512.9M USDMedian day 6.24M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Tempus AI, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:TEM · Home$54.04 USD-9.58 (-15.1%)7,423,785$57.99$58.35$53.26$63.62Close on Nov 20, 2026
BMV:TEM$1,143.36 MXN-28.05 (-2.4%)2$1,538.00$1,538.00$1,143.36$1,171.41Close on Nov 19, 2026
Frankfurt:F3M€50.69 EUR-4.01 (-7.3%)3,086€52.73€53.09€50.69€54.70Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:TEM · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$54.04-9.58-15.1%$57.99$58.35$53.267,423,785
$63.62+0.19+0.3%$63.88$65.24$61.715,348,138
$63.43-1.33-2.1%$67.12$67.31$61.796,141,978
$64.76-6.84-9.6%$69.05$69.08$64.564,995,234
$71.60-4.29-5.7%$75.65$75.72$68.485,285,693
$75.89-3.54-4.5%$75.11$77.70$71.614,804,028
$79.43-1.11-1.4%$83.15$85.10$79.254,198,832
$80.54-3.90-4.6%$82.37$83.43$78.164,965,707
$84.44+8.39+11.0%$77.60$85.75$76.438,106,536
$76.05+5.62+8.0%$70.95$76.85$70.226,271,218
$70.43-5.18-6.9%$72.35$72.64$65.079,957,595
$75.61-2.19-2.8%$78.74$81.60$72.755,914,441
$77.80-0.68-0.9%$80.75$84.47$77.606,295,134
$78.48+6.26+8.7%$74.31$83.42$70.3016,980,865
$72.22-5.62-7.2%$73.49$76.65$70.8610,418,259
$77.84+1.23+1.6%$75.50$78.40$75.354,778,018
$76.61+4.46+6.2%$72.09$77.51$71.756,869,177
$72.15+4.99+7.4%$67.18$72.89$66.505,066,128
$67.16-0.455-0.7%$67.60$68.00$64.033,765,810
$67.62+3.805+6.0%$63.94$68.15$62.674,679,300
$63.81-3.95-5.8%$66.10$68.29$61.516,204,200
$67.76+1.01+1.5%$66.88$68.93$66.003,382,400
$66.75+2.41+3.7%$63.80$69.07$63.204,994,500
$64.34-0.38-0.6%$66.38$67.70$63.504,176,500
$64.72-6.41-9.0%$70.89$72.50$63.796,873,100
$71.13+2.81+4.1%$64.77$72.81$63.606,667,500
$68.32+0.10+0.1%$67.00$71.35$66.356,064,800
$68.22+0.23+0.3%$67.12$68.78$66.174,152,600
$67.99-2.94-4.1%$69.89$70.25$67.033,800,300
$70.93+1.65+2.4%$70.20$72.96$69.206,273,300
$69.28-1.07-1.5%$68.86$69.75$66.717,476,400
$70.35-1.63-2.3%$70.10$73.09$68.669,013,700
$71.98-11.57-13.8%$84.97$87.99$71.3416,564,700
$83.55+6.92+9.0%$76.68$84.01$76.177,273,900
$76.63+0.13+0.2%$77.36$80.31$75.805,685,600
$76.50-5.40-6.6%$81.98$82.81$75.927,177,400
$81.90-0.68-0.8%$83.00$86.25$81.684,576,100
$82.58-2.50-2.9%$85.49$89.09$81.786,288,400
$85.08+0.07+0.1%$83.57$86.44$82.776,288,800
$85.01+2.77+3.4%$83.70$85.46$80.318,443,100
$82.24+5.65+7.4%$75.69$82.46$74.8110,821,300
$76.59-0.60-0.8%$76.47$78.97$75.885,369,900
$77.19-0.84-1.1%$77.99$79.00$75.815,998,200
$78.03+0.19+0.2%$79.08$80.25$77.135,633,400
$77.84-2.52-3.1%$81.40$81.83$75.999,311,600
$80.36+10.39+14.8%$72.70$81.28$72.6116,880,400
$69.97+1.12+1.6%$68.79$71.48$68.427,585,800
$68.85+6.64+10.7%$61.91$68.94$61.888,250,900
$62.21+3.20+5.4%$57.73$62.81$57.724,724,200
$59.01+0.27+0.5%$59.47$60.38$58.483,690,100
$58.74-2.54-4.1%$59.87$61.11$58.025,502,700
$61.28-3.01-4.7%$63.42$64.91$60.936,623,800
$64.29-0.33-0.5%$64.04$65.79$63.215,187,500
$64.62-0.04-0.1%$64.76$66.30$63.114,565,100
$64.66+2.72+4.4%$63.00$64.81$61.194,918,400
$61.94-0.33-0.5%$63.15$67.10$60.065,785,600
$62.27-0.78-1.2%$65.64$65.79$61.226,239,200
$63.05-0.99-1.5%$62.37$64.55$60.587,168,800
$64.04-6.65-9.4%$69.05$70.90$63.778,774,800
$70.69+2.21+3.2%$68.65$71.89$67.806,588,600
$68.48-0.25-0.4%$67.48$70.22$67.305,225,800
$68.73+2.56+3.9%$66.58$70.79$63.618,882,458
$66.17-6.52-9.0%$70.08$72.02$65.9311,929,280
$72.69+6.04+9.1%$65.60$72.96$65.2515,973,100
$66.65+5.40+8.8%$61.83$68.96$61.7020,144,400
Ticker
Hanover:F3M
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Hanover
Currency
EUR

What changed lately

Latest news

All Tempus AI, Inc. news

Tempus AI, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
71 in the last 12 months · 164 in all · newest Nov 19, 2026 · oldest 2024
Calls
10 calls with a replay · 10 with a transcript · latest Nov 2, 2026
Decks
18 decks · latest Nov 2, 2026

Where Tempus AI, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:TEM · Home listingNASDAQUnited StatesUSD
gettex:F3MgettexGermanyEUR
Tradegate:F3MTradegateGermanyEUR
BCBA:TEMBCBAArgentinaARS
BOATS:TEMBOATSUnited StatesUSD
BMV:TEMBMVMexicoMXN
Lang & Schwarz:A40EDPLang & SchwarzGermanyEUR
LS Exchange:A40EDPLS ExchangeGermanyEUR
Milan:1TEMMilanItalyEUR
Frankfurt:F3MFrankfurtGermanyEUR
BX Swiss:TEMUSDBX SwissSwitzerlandUSD
BCBA:TEMCBCBAArgentinaUSD
BCBA:TEMDBCBAArgentinaUSD
BIVA:TEMBIVAMexicoMXN
Munich:F3MMunichGermanyEUR
BX Swiss:TEMBX SwissSwitzerlandCHF
Dusseldorf:F3MDusseldorfGermanyEUR
Hamburg:F3MHamburgGermanyEUR
Stuttgart:F3MStuttgartGermanyEUR
BCBA:TEM.CIBCBAArgentinaARS
Hanover:F3M · This pageHanoverGermanyEUR
Xetra:F3MXetraGermanyEUR

Valuation

EV/sales 6.0× against a median of 4.3×: 7th lowest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$8.99B USD
P/E
Loss
EV/sales
6.0×
EV/EBITDA
Negative EBITDA
Price/book
19.1×
Gross margin
Not reported
Operating margin
−18.5%
Net margin
−12.5%
Debt to equity
0.0×
Beta vs S&P 500
2.51

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Tempus AI, Inc. · NASDAQ:TEMUS$9.58BUS$8.99Bn/a6.0×n/a19.1×−12.5%0.0×2.51
bioMerieux SA · EURONEXT:BIMUS$11.79BUS$11.53B27.0×2.6×10.9×2.5×9.8%0.1×n/a
Bio-Techne Corp · NASDAQ:TECHUS$11.41BUS$11.35B66.4×9.2×33.6×5.3×14.0%0.1×0.54
Qiagen N.V. · NYSE:QGENUS$10.18BUS$11.03B24.9×5.3×15.0×3.0×19.5%0.5×0.33
Avantor, Inc. · NYSE:AVTRUS$10.06BUS$13.28B29.8×2.0×14.7×1.7×5.1%0.6×0.78
WuXi XDC Cayman, Inc. · HKEX:2268US$9.64BUS$8.87B43.4×9.9×33.4×5.7×24.9%0.1×n/a
Bruker Corporation · NASDAQ:BRKRUS$8.62BUS$10.22Bn/a2.9×64.4×3.7×−3.5%0.7×1.72
Pharmaron Beijing Co., Ltd. Class A · SZSE:300759US$8.54BUS$8.25B32.1×3.4×n/a3.4×11.1%0.1×n/a
GenScript Biotech Corporation · HKEX:1548US$8.08BUS$7.50Bn/a7.8×22.8×2.1×−55.5%0.1×n/a
Bio-Rad Laboratories, Inc. · NYSE:BIOUS$7.84BUS$7.38B7.7×2.8×71.0×1.0×39.5%0.2×0.72
Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A · SZSE:300832US$7.53BUS$7.12B27.8×9.8×n/a5.3×37.2%0.0×n/a
Median of the othersUS$9.13BUS$9.54B28.8×4.3×28.1×3.2×12.5%0.1×0.72

Forecasts

8 strong buy · 2 buy · 10 hold · Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.

Price target
89.56 USD · Analysts' mean
EPS, year to Dec 2026
-0.10 · 13 analysts
Revenue, year to Dec 2026
1.6B · 20 analysts

Team and board

Officers

OfficerRole
Eric D. BelcherChief Executive Officer, Numerator
Eric LefkofskyFounder & Chief Executive Officer
Jim RogersChief Financial Officer
Mike YasiejkoPresident, Diagnostics
Ryan FukushimaPresident, Data & Apps
Andy PolovinChief Legal Officer
Caroline CornerInvestor Relations
Elizabeth KrutoholowTempus Investor Relations
Chris Scotto DiVettaSVP & GM, AI Applications
Christina AntoniouSVP, Head of Corporate Development
Erik PhelpsEVP & Chief Administrative & Legal Officer
Lauren SilvisSVP, External Affairs
Razik YousfiSVP & GM, AI Products
Ezra CohenChief Medical Officer, Data & Apps
Greg FisbeckChief Information Security Officer
Jennifer A. DoudnaLi Ka Shing Chancellor’s Professor of Biomedical Science, University of California, Berkeley and Founder, Innovative Genomics Institute
Kate SasserChief Scientific Officer
Laura ElsterChief Commercial Officer, Diagnostics
Melisa TuckerChief Data Officer
Robyn EckerlingChief Privacy Officer
Shane ColleyChief Technology Officer
Shane WoodsChief Strategy Officer & GM, Data Products
Stacey KraftChief People Officer
Ted LeonsisCofounder & Partner, Revolution Growth
TJ SlavinChief Medical Officer, Diagnostics

Board

DirectorRole
Peter J. BarrisChairman & General Partner, New Enterprise Associates
David EpsteinDirector
Eric D. BelcherChief Executive Officer, Numerator
Eric LefkofskyFounder & Chief Executive Officer
Jennifer A. DoudnaLi Ka Shing Chancellor’s Professor of Biomedical Science, University of California, Berkeley and Founder, Innovative Genomics Institute
Nadja WestDirector
Scott GottliebDirector
Theodore J. LeonsisDirector
Wayne A.I. FrederickDirector

Events

Calls

CallWhenStatus
Tempus AI (NASDAQ:TEM) Q3 2026 Earnings CallMon, Nov 02, 2026 · 8:45 AM ETReplay
Tempus AI (NASDAQ:TEM) Q2 2026 Earnings CallThu, Jul 30, 2026 · 4:30 PM ETReplay
Tempus AI (NASDAQ:TEM) Q1 2026 Earnings CallTue, May 05, 2026 · 4:30 PM ETReplay
Tempus AI (NASDAQ:TEM) Q4 2025 Earnings CallTue, Feb 24, 2026 · 4:30 PM ETReplay
Tempus AI (NASDAQ:TEM) Q3 2025 Earnings CallTue, Nov 04, 2025 · 4:30 PM ETReplay
Tempus AI (NASDAQ:TEM) Q2 2025 Earnings CallFri, Aug 08, 2025 · 8:00 AM ETReplay
Tempus AI (NASDAQ:TEM) Q1 2025 Earnings CallTue, May 06, 2025 · 4:30 PM ETReplay
Tempus AI (NASDAQ:TEM) Q4 2024 Earnings CallMon, Feb 24, 2025 · 4:30 PM ETReplay
Tempus AI (NASDAQ:TEM) Q3 2024 Earnings CallMon, Nov 04, 2024 · 4:30 PM ETReplay
Tempus AI (NASDAQ:TEM) Q2 2024 Earnings CallTue, Aug 06, 2024 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 2, 2026 · Before open+8.7%
Q2 2026Jul 30, 2026 · After close−0.9%
Q1 2026May 5, 2026 · After close−1.1%
Q4 2025Mar 2, 2026−3.5%
Q3 2025Nov 4, 2025 · After close−2.6%
Q2 2025Aug 8, 2025 · Before open+3.6%
Q1 2025May 6, 2025 · After close+12.6%
Q4 2024Feb 24, 2025−13.2%
Q3 2024Nov 4, 2024 · After close−10.1%
Q2 2024Aug 6, 2024 · After close−4.5%
All 11 quarters
QuarterResultsShare move
Q1 2024May 29, 2024

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings24 slidesNov 2, 2026
Q2 2026 Earnings PresentationEarnings26 slidesJul 30, 2026
Merger or Acquisition (July 2026)Merger or acquisition11 slidesJul 20, 2026
ESMO Congress 2025Conference12 slidesOctober 2025
Technical Presentation (September 2025)Technical12 slidesSeptember 2025
Q2 2025 Earnings PresentationEarnings30 slidesAug 8, 2025
Q1 2025 Earnings PresentationEarnings30 slidesMay 6, 2025
Technical Presentation (May 2025)Technical13 slidesMay 2025
Technical Presentation (March 2025)Technical14 slidesMarch 2025
Technical Presentation (November 2024)Technical13 slidesNovember 2024
All 18 decks
DeckKindSlidesDate
Technical Presentation (October 2023)Technical7 slidesOctober 2023
TCT 2023Conference7 slidesOctober 2023
Technical Presentation (2023)Technical7 slides2023
Technical Presentation (2023)Technical22 slides2023
Technical Presentation (November 2022)Technical19 slidesNovember 2022
ESMO GI 2022Conference22 slidesJul 1, 2022
Technical Presentation (December 2021)Technical14 slidesDec 7, 2021
Tempus Labs — Technical Presentation (December 2021)Technical5 slidesDecember 2021

Open Decks

Financings

RaiseDate
0.0% convertible senior notes due 2032
Closed: US$460M raised
Jul 30, 2026
0.75% convertible senior notes
Closed: US$750M raised
Use of proceeds: Strengthen the balance sheet and replace a portion of the existing term loan with lower-interest debt
Aug 8, 2025
Convertible Senior Notes due 2030
Announced: US$400M
Use of proceeds: Repay $274.7 million of senior secured term loans, pay for capped call transactions, and general corporate purposes
Jun 30, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$37.00 a share on Jun 13, 2024.

Price
US$37.00 a share
Shares offered
11,100,000 shares of Class A common stock
Offering size
US$410.7 million
Underwriters' option
Up to 1,665,000 more shares
Underwriters
MORGAN STANLEY, J.P. MORGAN, ALLEN & COMPANY LLC, BofA SECURITIES, TD COWEN, STIFEL, WILLIAM BLAIR, LOOP CAPITAL MARKETS, NEEDHAM & COMPANY · In the order on the cover

Steps

StepWhen
Draft sent to the SEC in confidenceSep 1, 2021
Filed publiclyMay 20, 2024
Amended twiceNewest Jun 13, 2024
Shares registered with an exchangeJun 11, 2024
Declared effective by the SECJun 13, 2024
Final prospectus, with the priceJun 17, 2024

Filings

FilingFiled
424B4 · ProspectusJun 17, 2024
EFFECT · Notice that a registration is effectiveJun 13, 2024
S-1/A · Registration statement, amendedJun 13, 2024
CERT · Exchange's certificate of listingJun 12, 2024
8-A12B · Registration of shares for listing on an exchangeJun 11, 2024
CORRESP · Letter to the SECJun 11, 2024
CORRESP · Letter to the SECJun 11, 2024
S-1/A · Registration statement, amendedJun 5, 2024
S-1 · Registration statementMay 20, 2024
DRS/A · Draft registration statement, amendedFeb 28, 2024
All 41 filings
FilingFiled
DRSLTR · Letter to the SEC with a draftDec 15, 2023
DRS/A · Draft registration statement, amendedDec 15, 2023
UPLOAD · Letter from the SECNov 21, 2023
DRS/A · Draft registration statement, amendedNov 13, 2023
DRSLTR · Letter to the SEC with a draftAug 25, 2023
DRS/A · Draft registration statement, amendedAug 25, 2023
DRSLTR · Letter to the SEC with a draftJul 26, 2023
UPLOAD · Letter from the SECMay 5, 2023
DRS/A · Draft registration statement, amendedApr 28, 2023
DRSLTR · Letter to the SEC with a draftApr 12, 2023
UPLOAD · Letter from the SECJan 27, 2023
DRS/A · Draft registration statement, amendedJan 17, 2023
DRSLTR · Letter to the SEC with a draftJan 13, 2023
UPLOAD · Letter from the SECOct 27, 2022
DRSLTR · Letter to the SEC with a draftOct 19, 2022
DRS/A · Draft registration statement, amendedOct 19, 2022
UPLOAD · Letter from the SECAug 3, 2022
DRSLTR · Letter to the SEC with a draftJul 22, 2022
UPLOAD · Letter from the SECMay 11, 2022
DRS/A · Draft registration statement, amendedApr 27, 2022
DRSLTR · Letter to the SEC with a draftFeb 14, 2022
UPLOAD · Letter from the SECDec 17, 2021
DRSLTR · Letter to the SEC with a draftDec 3, 2021
DRS/A · Draft registration statement, amendedDec 3, 2021
UPLOAD · Letter from the SECNov 29, 2021
UPLOAD · Letter from the SECNov 16, 2021
DRSLTR · Letter to the SEC with a draftOct 28, 2021
DRS/A · Draft registration statement, amendedOct 28, 2021
UPLOAD · Letter from the SECSep 30, 2021
DRSLTR · Letter to the SEC with a draftSep 1, 2021
DRS · Draft registration statementSep 1, 2021

Open IPO · From the cover of the final prospectus (424B4) filed Jun 17, 2024

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022
Revenue1.27B693.4M531.8M320.7M
Research and development172.9M149.3M90.3M83.2M
Selling, general and administrative731.7M755.4M296.8M233.4M
Operating income-252.9M-691.1M-196.1M-265.4M
Depreciation and amortization32.1M26.4M21.3M16.7M
EBITDA-220.8M-664.7M-174.8M-248.7M
Interest expense70.3M53.7M46.9M21.9M
Income before tax-291.1M-701.3M-213.5M-289.1M
Income tax-51.7M266.0K288.0K66.0K
Net income-245.0M-705.8M-214.1M-289.8M
Earnings per share, basic-1.41-6.23-4.20-5.30
Earnings per share, diluted-1.41-6.23-4.20-5.30

Balance sheet

LineFY2025FY2024FY2023FY2022
Cash and equivalents604.8M341.0M165.8M302.9M
Receivables311.2M154.8M94.5M
Inventory51.7M38.4M28.8M
Current assets1.17B667.6M350.3M
Property, plant and equipment89.2M58.1M61.7M
Goodwill470.2M73.3M73.4M53.1M
Total assets2.27B926.1M564.1M
Accounts payable82.0M53.8M54.4M
Current liabilities372.4M291.1M232.6M
Total liabilities1.78B869.8M840.7M
Shareholders' equity491.3M56.3M-1.38B-1.13B

Cash flow

LineFY2025FY2024FY2023FY2022
Cash from operations-218.1M-189.0M-214.3M-168.2M
Capital spending-21.0M-22.1M-34.6M-18.4M
Free cash flow-239.1M-211.2M-248.9M-186.6M
Cash from investing-398.4M-130.4M-40.3M-57.9M
Cash from financing884.1M494.3M117.5M251.4M
Dividends paid0-5.63M-5.63M-5.63M
Change in cash267.6M175.2M-137.1M25.3M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 19, 2026Insider tradeSEC
4 · Change in ownershipNov 19, 2026Insider tradeSEC
4 · Change in ownershipNov 19, 2026Insider tradeSEC
4 · Change in ownershipNov 19, 2026Insider tradeSEC
4 · Change in ownershipNov 19, 2026Insider tradeSEC
144 · Notice of proposed saleNov 19, 2026Other filingsSEC
8-K · Current reportNov 18, 2026Material contractSEC
144 · Notice of proposed saleNov 17, 2026Other filingsSEC
144 · Notice of proposed saleNov 17, 2026Other filingsSEC
144 · Notice of proposed saleNov 17, 2026Other filingsSEC
Show 200 filings
FilingDateTypeFiled with
144 · Notice of proposed saleNov 17, 2026Other filingsSEC
144 · Notice of proposed saleNov 17, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 6, 2026Big-stake noticeSEC
4 · Change in ownershipNov 4, 2026Insider tradeSEC
4 · Change in ownershipNov 4, 2026Insider tradeSEC
144 · Notice of proposed saleNov 2, 2026Other filingsSEC
10-Q · Quarterly reportNov 2, 2026Quarterly reportSEC
8-K · Current reportNov 2, 2026ResultsSEC
4 · Change in ownershipOct 29, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 28, 2026Big-stake noticeSEC
144 · Notice of proposed saleOct 27, 2026Other filingsSEC
8-K · Current reportOct 23, 2026Current reportSEC
EFFECT · Notice that a registration is effectiveOct 22, 2026Other filingsSEC
424B3 · ProspectusOct 21, 2026Offer documentSEC
S-4/A · Registration statement, amendedOct 20, 2026Offer documentSEC
S-4/A · Registration statement, amendedOct 2, 2026Offer documentSEC
4 · Change in ownershipSep 29, 2026Insider tradeSEC
144 · Notice of proposed saleSep 25, 2026Other filingsSEC
4 · Change in ownershipSep 24, 2026Insider tradeSEC
144 · Notice of proposed saleSep 22, 2026Other filingsSEC
4 · Change in ownershipSep 18, 2026Insider tradeSEC
4 · Change in ownershipSep 18, 2026Insider tradeSEC
4 · Change in ownershipSep 18, 2026Insider tradeSEC
4 · Change in ownershipSep 18, 2026Insider tradeSEC
144 · Notice of proposed saleSep 17, 2026Other filingsSEC
144 · Notice of proposed saleSep 17, 2026Other filingsSEC
144 · Notice of proposed saleSep 17, 2026Other filingsSEC
144 · Notice of proposed saleSep 16, 2026Other filingsSEC
425Sep 15, 2026Other filingsSEC
4 · Change in ownershipSep 3, 2026Insider tradeSEC
4 · Change in ownershipSep 3, 2026Insider tradeSEC
4 · Change in ownershipSep 3, 2026Insider tradeSEC
144 · Notice of proposed saleSep 1, 2026Other filingsSEC
144 · Notice of proposed saleSep 1, 2026Other filingsSEC
4 · Change in ownershipSep 1, 2026Insider tradeSEC
S-4 · Registration statementAug 31, 2026Offer documentSEC
4 · Change in ownershipAug 27, 2026Insider tradeSEC
4 · Change in ownershipAug 27, 2026Insider tradeSEC
144 · Notice of proposed saleAug 25, 2026Other filingsSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
144 · Notice of proposed saleAug 21, 2026Other filingsSEC
144 · Notice of proposed saleAug 21, 2026Other filingsSEC
4 · Change in ownershipAug 20, 2026Insider tradeSEC
4 · Change in ownershipAug 20, 2026Insider tradeSEC
4 · Change in ownershipAug 20, 2026Insider tradeSEC
4 · Change in ownershipAug 20, 2026Insider tradeSEC
4 · Change in ownershipAug 20, 2026Insider tradeSEC
4 · Change in ownershipAug 20, 2026Insider tradeSEC
144 · Notice of proposed saleAug 19, 2026Other filingsSEC
144 · Notice of proposed saleAug 19, 2026Other filingsSEC
144 · Notice of proposed saleAug 19, 2026Other filingsSEC
144 · Notice of proposed saleAug 19, 2026Other filingsSEC
144 · Notice of proposed saleAug 19, 2026Other filingsSEC
144 · Notice of proposed saleAug 19, 2026Other filingsSEC
144 · Notice of proposed saleAug 19, 2026Other filingsSEC
144 · Notice of proposed saleAug 19, 2026Other filingsSEC
144 · Notice of proposed saleAug 19, 2026Other filingsSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
144 · Notice of proposed saleAug 14, 2026Other filingsSEC
4 · Change in ownershipAug 14, 2026Insider tradeSEC
4 · Change in ownershipAug 11, 2026Insider tradeSEC
144 · Notice of proposed saleAug 7, 2026Other filingsSEC
4 · Change in ownershipAug 5, 2026Insider tradeSEC
4 · Change in ownershipAug 5, 2026Insider tradeSEC
144 · Notice of proposed saleAug 3, 2026Other filingsSEC
144 · Notice of proposed saleAug 3, 2026Other filingsSEC
4 · Change in ownershipJul 31, 2026Insider tradeSEC
4 · Change in ownershipJul 31, 2026Insider tradeSEC
4 · Change in ownershipJul 30, 2026Insider tradeSEC
10-Q · Quarterly reportJul 30, 2026Quarterly reportSEC
8-K · Current reportJul 30, 2026ResultsSEC
144 · Notice of proposed saleJul 28, 2026Other filingsSEC
SCHEDULE 13D/A · Big-stake notice, amendedJul 21, 2026Big-stake noticeSEC
425Jul 20, 2026Other filingsSEC
425Jul 20, 2026Other filingsSEC
425Jul 20, 2026Other filingsSEC
425Jul 20, 2026Other filingsSEC
8-K · Current reportJul 20, 2026Material contractSEC
425Jul 20, 2026Other filingsSEC
8-K · Current reportJul 20, 2026Current reportSEC
4 · Change in ownershipJul 10, 2026Insider tradeSEC
144 · Notice of proposed saleJul 8, 2026Other filingsSEC
4 · Change in ownershipJul 8, 2026Insider tradeSEC
144 · Notice of proposed saleJul 6, 2026Other filingsSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
4 · Change in ownershipJun 29, 2026Insider tradeSEC
4 · Change in ownershipJun 29, 2026Insider tradeSEC
144 · Notice of proposed saleJun 29, 2026Other filingsSEC
144 · Notice of proposed saleJun 25, 2026Other filingsSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
144 · Notice of proposed saleMay 27, 2026Other filingsSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
8-K · Current reportMay 22, 2026Meeting outcomeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
144 · Notice of proposed saleMay 20, 2026Other filingsSEC
144 · Notice of proposed saleMay 20, 2026Other filingsSEC
144 · Notice of proposed saleMay 20, 2026Other filingsSEC
144 · Notice of proposed saleMay 20, 2026Other filingsSEC
144 · Notice of proposed saleMay 20, 2026Other filingsSEC
144 · Notice of proposed saleMay 20, 2026Other filingsSEC
144 · Notice of proposed saleMay 20, 2026Other filingsSEC
4 · Change in ownershipMay 15, 2026Insider tradeSEC
8-K · Current reportMay 12, 2026Material contractSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 7, 2026Big-stake noticeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
10-Q · Quarterly reportMay 5, 2026Quarterly reportSEC
8-K · Current reportMay 5, 2026ResultsSEC
4 · Change in ownershipApr 30, 2026Insider tradeSEC
144 · Notice of proposed saleApr 28, 2026Other filingsSEC
144 · Notice of proposed saleApr 15, 2026Other filingsSEC
ARS · Annual report to shareholdersApr 7, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 7, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 7, 2026Meeting noticeSEC
4 · Change in ownershipMar 27, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 27, 2026Big-stake noticeSEC
144 · Notice of proposed saleMar 26, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeMar 6, 2026Big-stake noticeSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
3 · Initial statement of ownershipFeb 25, 2026Insider tradeSEC
S-8 · Registration statement for employee plansFeb 24, 2026Offer documentSEC
10-K · Annual reportFeb 24, 2026Annual reportSEC
8-K · Current reportFeb 24, 2026ResultsSEC
4 · Change in ownershipFeb 20, 2026Insider tradeSEC
4 · Change in ownershipFeb 20, 2026Insider tradeSEC
4 · Change in ownershipFeb 20, 2026Insider tradeSEC
4 · Change in ownershipFeb 20, 2026Insider tradeSEC
4 · Change in ownershipFeb 20, 2026Insider tradeSEC
4 · Change in ownershipFeb 20, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 20, 2026Other filingsSEC
144 · Notice of proposed saleFeb 20, 2026Other filingsSEC
144 · Notice of proposed saleFeb 19, 2026Other filingsSEC
144 · Notice of proposed saleFeb 19, 2026Other filingsSEC
144 · Notice of proposed saleFeb 19, 2026Other filingsSEC
144 · Notice of proposed saleFeb 19, 2026Other filingsSEC
144 · Notice of proposed saleFeb 19, 2026Other filingsSEC
144 · Notice of proposed saleFeb 19, 2026Other filingsSEC
144 · Notice of proposed saleFeb 19, 2026Other filingsSEC
144 · Notice of proposed saleFeb 19, 2026Other filingsSEC
4 · Change in ownershipFeb 13, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 10, 2026Big-stake noticeSEC
4 · Change in ownershipFeb 4, 2026Insider tradeSEC
4 · Change in ownershipJan 30, 2026Insider tradeSEC
144 · Notice of proposed saleJan 28, 2026Other filingsSEC
8-K · Current reportJan 12, 2026ResultsSEC
4 · Change in ownershipJan 7, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
144 · Notice of proposed saleDec 18, 2025Other filingsSEC
4 · Change in ownershipDec 18, 2025Insider tradeSEC
144 · Notice of proposed saleDec 16, 2025Other filingsSEC
4 · Change in ownershipDec 12, 2025Insider tradeSEC
144 · Notice of proposed saleDec 11, 2025Other filingsSEC
4 · Change in ownershipDec 9, 2025Insider tradeSEC
144 · Notice of proposed saleDec 5, 2025Other filingsSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
4 · Change in ownershipNov 28, 2025Insider tradeSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
144 · Notice of proposed saleNov 24, 2025Other filingsSEC
144 · Notice of proposed saleNov 24, 2025Other filingsSEC
4 · Change in ownershipNov 20, 2025Insider tradeSEC
4 · Change in ownershipNov 20, 2025Insider tradeSEC
4 · Change in ownershipNov 20, 2025Insider tradeSEC
4 · Change in ownershipNov 20, 2025Insider tradeSEC
4 · Change in ownershipNov 20, 2025Insider tradeSEC
4 · Change in ownershipNov 20, 2025Insider tradeSEC
144 · Notice of proposed saleNov 20, 2025Other filingsSEC

This page holds 200 of 525 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Tempus AI, Inc.’s releases · as of Jul 30, 2026

Common shares
177,357,848
Fully diluted
177,357,848

Fully diluted

LineShares
Common shares177,357,848

Share count over time

CountShares
Nov 22, 2026177,357,848

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard11.1M6.2%US$906MSep 30, 2026
BlackRock9.62M5.4%US$788MSep 30, 2026
ARK9.36M5.3%US$766MSep 30, 2026
Baillie Gifford & Co6.91M3.9%US$566MSep 30, 2026
Softbank Group Corp.5.41M3.0%US$443MSep 30, 2026
JPMorgan5.33M3.0%US$440MSep 30, 2026
Sumitomo Mitsui Trust Group, Inc.3.4M1.9%US$279MSep 30, 2026
Amova Asset Management Americas, Inc.3.4M1.9%US$278MSep 30, 2026
Franklin Templeton3.14M1.8%US$237MSep 30, 2026
UBS2.84M1.6%US$233MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
GC Wealth Management RIA, LLC2.41M1.4%US$197MSep 30, 2026
Geode Capital2.18M1.2%US$178MSep 30, 2026
Morgan Stanley2.08M1.2%US$170MSep 30, 2026
Citadel2.06M1.2%US$169MSep 30, 2026
State Street1.98M1.1%US$162MSep 30, 2026
D. E. Shaw & Co., Inc.1.77M1.00%US$145MSep 30, 2026
AQR Capital Management LLC1.67M0.94%US$137MSep 30, 2026
Alphabet Inc.1.55M0.87%US$127MSep 30, 2026
Lingotto Investment Management LLP1.41M0.79%US$115MSep 30, 2026
Jane Street1.36M0.77%US$111MSep 30, 2026
BNP Paribas1.27M0.71%US$104MSep 30, 2026
Alyeska Investment Group, L.P.1.17M0.66%US$95.6MSep 30, 2026
Clear Street Group Inc.1.02M0.58%US$83.7MSep 30, 2026
Invesco1.02M0.58%US$83.6MSep 30, 2026
T. Rowe Price950K0.54%US$77.8MSep 30, 2026
Tudor Investment Corp Et Al938K0.53%US$76.9MSep 30, 2026
Goldman Sachs932K0.53%US$76.4MSep 30, 2026
Schwab877K0.49%US$71.8MSep 30, 2026
Legal & General869K0.49%US$71.2MSep 30, 2026
Bamco Inc864K0.49%US$70.7MSep 30, 2026
Two Sigma851K0.48%US$69.7MSep 30, 2026
Susquehanna797K0.45%US$65.3MSep 30, 2026
Bank of America757K0.43%US$62MSep 30, 2026
Northern Trust601K0.34%US$49.2MSep 30, 2026
Nuveen529K0.30%US$43.3MSep 30, 2026
Pictet Asset Management Holding SA503K0.28%US$41.2MSep 30, 2026
Barclays467K0.26%US$38.2MSep 30, 2026
First Trust457K0.26%US$37.4MSep 30, 2026
Point72 Asset Management, L.P.455K0.26%US$37.3MSep 30, 2026
Casdin Capital, LLC424K0.24%US$34.7MSep 30, 2026
SRS Investment Management, LLC402K0.23%US$33MSep 30, 2026
Jump Financial, LLC401K0.23%US$32.9MSep 30, 2026
abrdn401K0.23%US$32.9MSep 30, 2026
Tairen Capital Ltd393K0.22%US$32.2MSep 30, 2026
BNY383K0.22%US$31.4MSep 30, 2026
Citigroup Inc376K0.21%US$30.8MSep 30, 2026
Capital Impact Advisors, LLC372K0.21%US$30.5MSep 30, 2026
Contrarius Group Holdings Ltd360K0.20%US$29.5MSep 30, 2026
IQ EQ FUND MANAGEMENT (IRELAND) Ltd349K0.20%US$28.6MSep 30, 2026
Wells Fargo329K0.19%US$27MSep 30, 2026

This page holds 50 of 548 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
ARK Innovation ETF6.2M3.5%US$272MJul 31, 2026
Vanguard Total Stock Market Index Fund3.6M2.0%US$209MJun 30, 2026
Vanguard Small-Cap Index Fund2.6M1.5%US$151MJun 30, 2026
ARK Genomic Revolution ETF2.33M1.3%US$102MJul 31, 2026
Vanguard U.S. Growth Fund2.2M1.2%US$111MMay 31, 2026
Vanguard Small-Cap Growth Index Fund1.5M0.85%US$87MJun 30, 2026
Vanguard Extended Market Index Fund1.18M0.67%US$68.5MJun 30, 2026
ERShares Private-Public Crossover ETF775K0.44%US$44.9MJun 30, 2026
Franklin Dynatech Fund750K0.42%US$43.4MJun 30, 2026
iShares Biotechnology ETF749K0.42%US$43.4MJun 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
JPMorgan U.S. Tech Leaders ETF673K0.38%US$39MJun 30, 2026
Baron Discovery Fund639K0.36%US$37MJun 30, 2026
iShares Russell Mid-Cap Growth ETF635K0.36%US$36.8MJun 30, 2026
iShares Future AI & Tech ETF601K0.34%US$34.8MJun 30, 2026
Fidelity Extended Market Index Fund525K0.30%US$26.5MMay 31, 2026
iShares Russell Mid-Cap ETF441K0.25%US$25.6MJun 30, 2026
Fidelity Mid Cap Index Fund410K0.23%US$18MJul 31, 2026
iShares Russell 1000 Growth ETF408K0.23%US$23.7MJun 30, 2026
The Hartford Midcap Fund315K0.18%US$13.8MJul 31, 2026
Vanguard Health Care Index Fund278K0.16%US$14MMay 31, 2026
Schwab U.S. Mid-Cap ETF275K0.16%US$13.9MMay 31, 2026
Patient Opportunity Trust250K0.14%US$14.5MJun 30, 2026
Schwab U.S. Large-Cap Growth ETF222K0.13%US$11.2MMay 31, 2026
First Trust Nasdaq Artificial Intelligence and Robotics ETF216K0.12%US$12.5MJun 30, 2026
ROBO Global Artificial Intelligence ETF204K0.11%US$8.93MJul 31, 2026
Fidelity Total Market Index Fund192K0.11%US$9.7MMay 31, 2026
Franklin Growth Opportunities Fund186K0.11%US$8.18MJul 31, 2026
American Beacon ARK Transformational Innovation Fund180K0.10%US$10.4MJun 30, 2026
Goldman Sachs U.S. Tax-Managed Equity Fund173K0.10%US$10MJun 30, 2026
Vanguard Russell 1000 Growth Index Fund163K0.09%US$8.24MMay 31, 2026
Fidelity Series Total Market Index Fund155K0.09%US$7.82MMay 31, 2026
First Trust Health Care AlphaDEX Fund153K0.09%US$6.71MJul 31, 2026
KraneShares Artificial Intelligence and Technology Public and Private ETF144K0.08%US$8.34MJun 30, 2026
Fidelity Large Cap Growth Index Fund142K0.08%US$6.21MJul 31, 2026
iShares Core S&P Total U.S. Stock Market ETF135K0.08%US$7.8MJun 30, 2026
JNL Multi-Manager Small Cap Growth Fund132K0.07%US$7.67MJun 30, 2026
MFS New Discovery Fund129K0.07%US$6.52MMay 31, 2026
Fidelity Mid Cap Growth Index Fund115K0.06%US$6.66MJun 30, 2026
Schwab U.S. Large-Cap ETF110K0.06%US$5.56MMay 31, 2026
Fidelity Nasdaq Composite Index Fund105K0.06%US$5.31MMay 31, 2026
Goldman Sachs Large Cap Growth Insights Fund99,3250.06%US$4.36MJul 31, 2026
BlackRock Advantage Small Cap Core Fund91,9570.05%US$4.64MMay 29, 2026
Vanguard Strategic Equity Fund91,5810.05%US$5.31MJun 30, 2026
Invesco NASDAQ Next Gen 100 ETF89,7350.05%US$4.53MMay 31, 2026
Vanguard Total World Stock Index Fund88,6170.05%US$3.89MJul 31, 2026
Vanguard Explorer Fund85,3170.05%US$3.74MJul 31, 2026
Nuveen Equity Index Fund84,2940.05%US$3.7MJul 31, 2026
iShares U.S. Small-Cap Equity Factor ETF79,6630.04%US$3.49MJul 31, 2026
Nuveen Quant Small/Mid Cap Equity Fund75,1000.04%US$3.29MJul 31, 2026
iShares Russell 1000 ETF74,7990.04%US$4.33MJun 30, 2026

This page holds 50 of 212 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale5,367USD 62.33US$335KNov 17, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale10,225USD 63.23US$647KNov 17, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale1,482USD 64.02US$94,878Nov 17, 2026
Bartolucci Ryan M
Officer: Chief Accounting Officer
Sale482USD 62.33US$30,043Nov 17, 2026
Bartolucci Ryan M
Officer: Chief Accounting Officer
Sale925USD 63.23US$58,488Nov 17, 2026
Bartolucci Ryan M
Officer: Chief Accounting Officer
Sale133USD 64.02US$8,515Nov 17, 2026
Polovin Andrew
Officer: EVP, Chief Legal Officer
Sale2,103USD 62.33US$131KNov 17, 2026
Polovin Andrew
Officer: EVP, Chief Legal Officer
Sale4,020USD 63.23US$254KNov 17, 2026
Polovin Andrew
Officer: EVP, Chief Legal Officer
Sale581USD 64.02US$37,196Nov 17, 2026
Fukushima Ryan
Officer: CEO, Data
Sale3,223USD 62.33US$201KNov 17, 2026
Show 50 trades
TradeTradeSharesPriceValueDate
Fukushima Ryan
Officer: CEO, Data
Sale6,134USD 63.23US$388KNov 17, 2026
Fukushima Ryan
Officer: CEO, Data
Sale890USD 64.02US$56,978Nov 17, 2026
Rogers James William
Officer: Chief Financial Officer
Sale2,225USD 62.33US$139KNov 17, 2026
Rogers James William
Officer: Chief Financial Officer
Sale4,240USD 63.23US$268KNov 17, 2026
Rogers James William
Officer: Chief Financial Officer
Sale614USD 64.02US$39,308Nov 17, 2026
Epstein David R
Director
Sale370USD 74.29US$27,487Nov 2, 2026
Fukushima Ryan
Officer: CEO, Data
Sale80USD 74.29US$5,943Nov 2, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale10,428USD 67.36US$702KOct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale14,820USD 70.58US$1.05MOct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale38,489USD 71.56US$2.75MOct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale35,759USD 72.31US$2.59MOct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale1,282USD 67.36US$86,356Oct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale961USD 68.00US$65,348Oct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale195USD 69.28US$13,510Oct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale824USD 70.58US$58,158Oct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale2,167USD 71.56US$155KOct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale2,071USD 72.31US$150KOct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale9,132USD 67.36US$615KOct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale7,592USD 68.00US$516KOct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale6,636USD 68.00US$451KOct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale1,300USD 69.28US$90,064Oct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale5,486USD 70.58US$387KOct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale14,237USD 71.56US$1.02MOct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale13,209USD 72.31US$955KOct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale1,495USD 69.28US$104KOct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale6,312USD 70.58US$446KOct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale16,414USD 71.56US$1.17MOct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale15,259USD 72.31US$1.1MOct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale24,597USD 67.36US$1.66MOct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale17,825USD 68.00US$1.21MOct 27, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale3,510USD 69.28US$243KOct 27, 2026
Schoenherr Thomas Edward
Officer: CEO, Diagnostics
Sale10,281USD 85.00US$874KSep 25, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale7,394USD 76.57US$566KSep 22, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale33,770USD 77.29US$2.61MSep 22, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale16,152USD 78.23US$1.26MSep 22, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale184USD 78.86US$14,510Sep 22, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale17,359USD 76.57US$1.33MSep 22, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale79,259USD 77.29US$6.13MSep 22, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale37,950USD 78.23US$2.97MSep 22, 2026
Lefkofsky Eric P
Director, Officer: CEO and Chairman, 10% owner
Sale432USD 78.86US$34,068Sep 22, 2026

This page holds 50 of 174 trades. Open Shareholders

Big stakes

StakeStakeSharesDateFiling
Eric Paul Lefkofsky24.00%42.8MDec 31, 2025Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Peter Barris
Other companies: Sprout Social, Inc (Lead Independent Director · Since at least Dec 12, 2019); ZeroFox Holdings Inc. (Director · Aug 3, 2022 – Dec 14, 2022 · Past); NextNav Inc. (Director · Oct 28, 2021 – Jun 22, 2022 · Past); Berkshire Grey Inc (Director · Jul 21, 2021 – Jul 20, 2023 · Past); Groupon, Inc. (Director · Apr 21, 2016 – Jul 21, 2022 · Past)
Chairman & General Partner, New Enterprise Associates · Since at least Jun 13, 2024
Scott Gottlieb
Other companies: UnitedHealth Group Incorporated (Director · Since at least Nov 18, 2025); Illumina, Inc. (Chair of the Board · Since at least Feb 4, 2020); Pfizer, Inc. (Director · Since at least Jun 27, 2019); Targeted Medical Pharma Inc (Director · Jul 22, 2013 – Jul 22, 2013 · Past); CombiMatrix Corp (Director · Jan 15, 2009 – May 9, 2016 · Past)
Director · Since at least Jun 13, 2024
Wayne A.I. Frederick
Other companies: Humana Inc. (Director · Since at least Dec 31, 2022); Workday, Inc. (Independent Director · Since at least Jun 22, 2022); Insulet Corporation (Director · Since at least May 24, 2022); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Oct 14, 2022 · Past)
Director · Since at least Jun 13, 2024
David R. Epstein
Other companies: AgomAb Therapeutics NV (Chairman of the Board · Since at least Mar 18, 2026); Pfizer, Inc. (Director · Apr 13, 2026 – Nov 5, 2026 · Past); Seagen Inc (CEO, Director · Nov 10, 2023 – Dec 14, 2023 · Past)
Director · Since at least Jun 13, 2024
Eric Lefkofsky
Other companies: Groupon, Inc. (Director · Nov 3, 2011 – Jun 15, 2022 · Past); Echo Global Logistics Inc (Director · Oct 1, 2009 – Mar 1, 2013 · Past); InnerWorkings Inc (Director · Sep 2, 2008 – Aug 15, 2012 · Past)
Founder & Chief Executive Officer · Since at least Jun 13, 2024
Nadja West
Other companies: Johnson & Johnson (Director · Since at least Dec 3, 2020); Tenet Healthcare Corporation (Director · Since at least Oct 8, 2019); Nucor Corporation (Director · Since at least Sep 5, 2019)
Director · Since at least Jun 13, 2024
Theodore Leonsis
Other companies: Groupon, Inc. (Chairman · Since at least Nov 3, 2011); American Express Company (Director · Since at least Jul 19, 2010); Rosetta Stone Inc (Director · Dec 7, 2009 – May 23, 2012 · Past)
Director · Since at least Jun 13, 2024
Ryan M Bartolucci
Other companies: Surgalign Holdings Inc (VP, Chief Accounting Officer · Mar 8, 2019 – Sep 25, 2020 · Past); RTI Surgical Holdings Inc (VP Corporate Controller · Sep 25, 2018 – Mar 8, 2019 · Past)
Chief Accounting Officer · Since at least Jun 13, 2024
Eric Belcher
Other companies: InnerWorkings Inc (Director · Aug 15, 2006 – Dec 31, 2018 · Past)
Chief Executive Officer, Numerator · Since at least Jun 13, 2024
Jennifer Doudna
Other companies: Johnson & Johnson (Director · Since at least Apr 26, 2018)
Li Ka Shing Chancellor’s Professor of Biomedical Science, University of California, Berkeley and Founder, Innovative Genomics Institute · Since at least Jun 13, 2024
All 35 people
PersonSeat
Andrew PolovinEVP, Chief Legal Officer · Since at least Jun 13, 2024
Andy PolovinChief Legal Officer · Since at least Sep 18, 2026
Caroline CornerInvestor Relations · Since at least Jul 20, 2026
Chris Scotto DiVettaSVP & GM, AI Applications · Since at least Sep 11, 2025
Christina AntoniouSVP, Head of Corporate Development · Since at least Nov 4, 2026
Elizabeth KrutoholowTempus Investor Relations · Since at least May 29, 2026
Erik PhelpsEVP & Chief Administrative & Legal Officer · Since at least Jun 13, 2024
Ezra CohenChief Medical Officer, Data & Apps · Since at least Oct 19, 2026
Greg FisbeckChief Information Security Officer · Since at least Nov 4, 2026
James William RogersChief Financial Officer · Since at least Jun 13, 2024
Jim RogersChief Financial Officer · Since at least Aug 20, 2026
Kate SasserChief Scientific Officer · Since at least May 29, 2026
Laura ElsterChief Commercial Officer, Diagnostics · Since at least May 21, 2026
Lauren SilvisSVP, External Affairs · Since at least Oct 26, 2026
Melisa TuckerChief Data Officer · Since at least Nov 4, 2026
Mike YasiejkoPresident, Diagnostics · Since at least May 20, 2025
Razik YousfiSVP & GM, AI Products · Since at least Aug 4, 2026
Robyn EckerlingChief Privacy Officer · Since at least Nov 4, 2026
Ryan FukushimaPresident, Data & Apps · Since at least Jun 13, 2024
Shane ColleyChief Technology Officer · Since at least May 27, 2026
Shane WoodsChief Strategy Officer & GM, Data Products · Since at least Nov 4, 2026
Stacey KraftChief People Officer · Since at least Nov 4, 2026
Ted LeonsisCofounder & Partner, Revolution Growth · Since at least Nov 4, 2026
Thomas Edward SchoenherrCEO, Diagnostics · Since at least Feb 20, 2026
TJ SlavinChief Medical Officer, Diagnostics · Since at least Nov 4, 2026

Open People

Log in to ask 6ix AI your own questions about Tempus AI, Inc.